EE518 An Updated Cost-Effectiveness Analysis of Axicabtagene Ciloleucel in Second-Line Large B-Cell Lymphoma Patients in the United States
Abstract
Authors
O. Oluwole A. Patel S. Vadgama N. Smith R.S. Blissett C. Feng M. Dickinson P. Johnston M.A. Perales